Daniel MacLachlan, Chief Financial Officer of Red Violet, Inc. (NASDAQ:RDVT), recently reported a significant sale of company common stock. On June 1, 2026, MacLachlan divested shares totaling $689,160 in value. The total divestment covered 12,000 shares of the company's common stock, with the weighted average prices per share for the two separate blocks falling within a narrow range of $57.24 and $57.62.
These sales were structured into two distinct transactions. The initial block involved the sale of 6,000 shares, priced at a weighted average of $57.62 per share. Individual transaction prices for this portion ranged from $57.45 to $58.07. Subsequently, a second transaction accounted for the remaining 6,000 shares, which were sold with a weighted average price of $57.24 per share. The specific pricing range observed during this second sale was between $57.00 and $57.78.
The reported timing of these sales is notable because the stock had experienced substantial upward movement in the preceding week, surging by 17%. Currently, RDVT trades at $59.30. Furthermore, analysis from InvestingPro suggests that this current trading level exceeds the company's calculated Fair Value, positioning the stock among those considered potentially overvalued.
Despite the executive selling activity, Red Violet Inc. has recently provided figures indicating strong operational performance. In its financial report for the first quarter of 2026, the company announced results that exceeded both earnings and revenue forecasts. Specifically, Red Violet achieved an impressive Earnings Per Share (EPS) of $0.46 per share. This figure notably surpassed the anticipated EPS of $0.33. Additionally, quarterly revenue reached $25.8 million, which was higher than the forecasted amount of $25.17 million.
These financial developments highlight a period of strong performance for Red Violet in the recent quarter. The company's success during this reporting period is considered a noteworthy achievement by both investors and analysts assessing the firm's current market standing.
Following the reported stock sales, MacLachlan maintains direct ownership of 358,902 shares of Red Violet common stock. This total holding includes 52,853 restricted stock units (RSUs). These RSUs are convertible into common stock on a one-for-one basis and are scheduled to vest across several dates: December 1, 2026; November 1, 2026; November 1, 2027; December 1, 2027; and December 1, 2028. In addition to his common stock holdings and RSUs, MacLachlan holds an indirect stake of 466 shares through an IRA.
The confluence of these two sets of information- executive selling activity against the backdrop of strong quarterly financial metrics- presents a complex picture for market participants evaluating RDVT's trajectory. Investors seeking deeper insight into Red Violet’s valuation and exploring further analysis are advised to consult comprehensive resources available on specialized platforms.
Risks
- Risk 1: Valuation Concerns
- The current market price of $59.30 is noted by InvestingPro analysis to be above the stock's calculated Fair Value, suggesting potential overvaluation in the short term.
- Risk 2: Executive Selling Pressure (Indirect Impact on Market Sentiment)
More from Insider Trading
Risks
- Risk 1: Valuation Concerns
- The current market price of $59.30 is noted by InvestingPro analysis to be above the stock's calculated Fair Value, suggesting potential overvaluation in the short term.
- Risk 2: Executive Selling Pressure (Indirect Impact on Market Sentiment)